Best for 0% commission stocks
Capital at risk. T&Cs apply.
Copy picks from top traders
Commission-free trades
Fractional shares
Get dividend payments
Fractional shares
Get dividend payments
Moderna is a US biotechnology company. Its COVID-19 vaccine was approved for use in the UK on 8 January, 2021 - the third vaccine to get this approval. Moderna is expanding its production capability in Europe and UK supplies are expected in spring 2021.
Moderna's share price rose after it announced encouraging early results from vaccine trials in November 2020, so news of an approved vaccine could see the share price rise further. The company uses a molecule called "messenger RNA" (or mRNA), which exists in the cells in your body, to produce medicines. We've compiled what you need to know about how to buy Moderna shares.
How to buy shares in Moderna
- Open a brokerage account. Choose from our top broker picks or compare brokers in depth. Then, complete an application.
- Fund your account. Add money to your account via bank transfer, debit card or credit card.
- Search the platform by ticker symbol. MRNA in this case.
- Choose an order type. Place a market order or limit order with your preferred number of shares or dollar amount.
- Submit the order. It's that simple.
Our top picks for where to buy Moderna shares
Best for fractional shares
Capital at risk. T&Cs apply.
Earn 4.75% on uninvested funds
Commission-free trades
Fractional shares
5,400+ stocks/ETFs
Fractional shares
5,400+ stocks/ETFs
Best for customer satisfaction
Capital at risk. T&Cs apply.
97% would recommend
Free fund trading
Expert insights
Wide range of accounts
Expert insights
Wide range of accounts
Fees calculator for buying Moderna shares with popular apps
Both exchange rates and share prices fluctuate in real time, so the costs estimated here should be considered as a guide only. They don't factor in spreads, which can be hard to pin down. Always refer to the platform itself for availability and pricing.
Quantity of shares
20
| Platform | Finder Score | Account fee | Min. initial deposit | Trade cost | Link |
|---|---|---|---|---|---|
|
9
Excellent
|
£0 | $100 | £608.47 |
Go to siteCapital at risk
|
 |
9.1
Excellent
|
£0 | £1 | £609.92 |
Go to siteCapital at risk
|
|
9
Excellent
|
£0 | £0 | £606.96 |
Go to siteCapital at risk
|
 |
9
Excellent
|
£0 | £0 | £606.96 |
Go to siteCapital at risk
|
|
8.5
Great
|
£0 (0.45% for funds) | £1 | £621.93 |
Go to siteCapital at risk
|
 |
9.3
Excellent
|
0% - 0.25% | £100 | N/A |
Go to siteCapital at risk
|
Full comparison of share dealing platforms
These providers cover a wide range of stocks, but we can't guarantee they'll all offer this stock.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Alternative ways to invest in Moderna
Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including Moderna), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.
Moderna is a major part of the NASDAQ, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).
Is it a good time to buy Moderna stock?
Review technicals and fundamentals to help you determine if now's a good time for you to invest.
Technical analysis
View Moderna's price performance, share price volatility, historical data and technicals.
Use our graph to track the performance of MRNA stock over time.
Historical closes compared with the last close of $38.36
| 1 week (2024-12-11) | -30.03% |
|---|---|
| 1 month (2024-11-18) | -40.01% |
| 3 months (2024-09-18) | -68.59% |
| 6 months (2024-06-18) | -64.47% |
| 1 year (2023-12-18) | -50.03% |
| 2 years (2022-12-18) | -71.91% |
| 3 years (2021-12-18) | -89.03% |
| 5 years (2019-12-18) | 125.51% |
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
Invest in Moderna shares
Finder AwardFree Trades
- Over 5,500+ stocks from 20 exchanges
- Free to open an account
- Commission-free trading
Go to site
Capital at risk
Other fees may apply
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is Moderna under- or over-valued?
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Moderna P/E ratio, PEG ratio and EBITDA.
Moderna's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, Moderna's shares trade at around 0x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the United States stock markets on average as of November 09, 2023 (20.44). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Frequently asked questions
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Ready to compare platforms?More resources on Finder
More guides on Finder
-
Best day trading stocks for 2024
Find out how to spot some of the best day trading stocks available in the UK and abroad, along with tips for managing your investment portfolio on a day-to-day basis.
-
10 Best trading platforms in the UK for 2024
We’ve tested, analysed and scored trading platforms to find the 10 best trading platforms in the UK, who they’re best for and the pros and cons.
-
How to invest in Web3
Find out what Web3 is all about, including pros and cons of Web3 and how you can invest.
-
Best investment platforms paying high interest on cash
Some trading apps and platforms now offer competitive interest rates on uninvested cash.
-
Best trading apps UK
We’ve tested, analysed and scored trading apps to find the 10 best trading apps in the UK, who they’re best for and the pros and cons.
-
6 best forex trading platforms in the UK
We have listed the top forex trading platforms in the UK, who they’re best for and the pros and cons.
-
Best trading apps for beginners
We’ve reviewed the best online trading platforms in the UK and explained why they’re best suited to beginners, with pros and cons.
-
Best junior stocks and shares ISAs
A junior stocks and shares ISA account (JISA) is a tax-efficient way to save for your child’s future, here are the best options and how to compare.
-
Best stocks and shares ISA in the UK
We’ve reviewed the best stocks and shares ISA accounts in the UK, explaining who they might suit and what the benefits and drawbacks are.
-
Best shares to buy now: Updated daily
Find out how to choose the best shares to buy now, see our list of the top 30 trending stocks today, and find out why they’re trending.